BioMedican
About this raise
BioMedican, with a valuation of $56.4 million, is raising funds on Wefunder. The company makes cannabinoids through the process of biosynthesis. The pharmaceutical-grade cannabinoids of BioMedican are bio-organic, non-GMO, and cost 70-90% less than the current wholesale price. The company has research partnerships with the Institute of Genetics Moscow, Imperial College UK, and Denmark Technical University. The current crowdfunding campaign has a minimum target of $200,000 and a maximum target of $1,069,999. The campaign proceeds will be used for starting a pilot-scale fermentation equipment, buying additional equipment, usage of analytical services, and operational expenses.
Investment Overview
Invested : $220,467
Deal Terms
Total Commitments
- Platform
- Wefunder
- Start Date
- 08/13/2021
- Close Date
- 10/02/2021
$200,000
$1,069,999
$250
Equity - Preferred
Seed
RegCF
$4.50
$50,124,520
$56,390,085
Company & Team
Company
- Year Founded
- 2017
- Industry
- Healthcare & Pharmaceuticals
- Tech Sector
- Distribution Model
- B2B
- Margin
- Low
- Capital Intensity
- High
Upgrade to gain access
-
$12.50 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific
Kingscrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual
Edge
Ratings 
Company Funding & Growth
Funding history
| Close Date | Platform | Valuation | Total Raised | Security Type | Status | Reg Type |
|---|---|---|---|---|---|---|
| 10/02/2021 | Wefunder | $56,390,085 | $220,467 | Equity - Preferred | Funded | RegCF |